Aging profoundly remodels the immune system, impairing defense, repair and homeostatic function across tissues. Because the immune system operates in every organ, its deterioration has been proposed to drive or exacerbate systemic dysfunction and accelerate overall biological aging, making it an attractive biomarker and target for geroscience-guided trials. Despite this central role, there is no consensus on how to quantify immune aging, especially in clinical trials. Here, we establish a translational framework to identify immune aging biomarkers for this purpose. We define five evaluation criteria for immune aging biomarkers and apply these to candidate biomarkers, discussing their utility in the context of a major international healthspan competition, XPRIZE Healthspan. Metrics encapsulating multidimensional aspects of immune function, inflammaging scores and functional assays performed best against our selection criteria. Finally, we identify promising emerging measures, together with critical gaps that must be addressed to develop reliable, predictive biomarkers of human immune competence. Our framework provides a coherent path toward actionable and clinically meaningful immune aging biomarkers capable of quantifying immune fitness and resilience, and accelerating the clinical translation of geroscience-guided interventions.
Aging profoundly remodels the immune system, impairing defense, repair and homeostatic function across tissues. Because the immune system operates in every organ, its deterioration has been proposed to drive or exacerbate systemic dysfunction and accelerate overall biological aging, making it an attractive biomarker and target for geroscience-guided trials. Despite this central role, there is no consensus on how to quantify immune aging, especially in clinical trials. Here, we establish a translational framework to identify immune aging biomarkers for this purpose. We define five evaluation criteria for immune aging biomarkers and apply these to candidate biomarkers, discussing their utility in the context of a major international healthspan competition, XPRIZE Healthspan. Metrics encapsulating multidimensional aspects of immune function, inflammaging scores and functional assays performed best against our selection criteria. Finally, we identify promising emerging measures, together with critical gaps that must be addressed to develop reliable, predictive biomarkers of human immune competence. Our framework provides a coherent path toward actionable and clinically meaningful immune aging biomarkers capable of quantifying immune fitness and resilience, and accelerating the clinical translation of geroscience-guided interventions.
Kuo, P. -L. et al. Longitudinal phenotypic aging metrics in the Baltimore longitudinal study of aging. Nat. Aging 2 , 635–643 (2022).
Kennedy, B. K. et al. Geroscience: linking aging to chronic disease. Cell 159 , 709–713 (2014).
Justice, J. N. XPRIZE healthspan is a global competition to restore function. Nat. Aging 4 , 165–166 (2024).
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186 , 243–278 (2023).
Yousefzadeh, M. J. et al. An aged immune system drives senescence and ageing of solid organs. Nature 594 , 100–105 (2021).
Bartleson, J. M. et al. SARS-CoV-2, COVID-19 and the aging immune system. Nat. Aging 1 , 769–782 (2021).
Lord, J. M. et al. Accelerated immune ageing is associated with COVID-19 disease severity. Immun. Ageing 21 , 6 (2024).
Wu, F. et al. Immunological biomarkers of aging. J. Immunol. 214 , 889–902 (2025).
Sender, R. et al. The total mass, number, and distribution of immune cells in the human body. Proc. Natl Acad. Sci. USA 120 , e2308511120 (2023).
Terekhova, M., Bohacova, P. & Artyomov, M. N. Human immune aging. Immunity 58 , 2646–2669 (2025).
Doherty, T. M., Weinberger, B., Didierlaurent, A. & Lambert, P. -H. Age-related changes in the immune system and challenges for the development of age-specific vaccines. Ann. Med. 57 , 2477300 (2025).
Kulkarni, U. et al. Excessive neutrophil levels in the lung underlie the age-associated increase in influenza mortality. Mucosal Immunol. 12 , 545–554 (2019).
Chen, J., Kelley, W. J. & Goldstein, D. R. Role of aging and the immune response to respiratory viral infections: potential implications for COVID-19. J. Immunol. 205 , ji2000380 (2020).
Smith, C. A., Kulkarni, U., Chen, J. & Goldstein, D. R. Influenza virus inoculum volume is critical to elucidate age-dependent mortality in mice. Aging Cell 18 , e12893 (2019).
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14 , 576–590 (2018).
Fulop, T. et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?. Front. Immunol. 8 , 1960 (2018).
Ferrucci, L. & Fabbri, E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol. 15 , 505–522 (2018).